We are live on ! Find out more
ANEB

Anebulo Pharmaceuticals

Delisted

ANEB was delisted on the 27th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
2L
1
22NW LP
Washington
$20.1M
NCM
2
Nantahala Capital Management
Connecticut
$3.95M
MP
3
Mangrove Partners
Connecticut
$3.28M
Morgan Stanley
4
Morgan Stanley
New York
$519K -$30.6K -20,775 -5%
LA
5
LVW Advisors
New York
$455K -$416K -282,899 -45%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$267K +$168K +114,077 +125%
Vanguard Group
7
Vanguard Group
Pennsylvania
$266K +$74.3K +50,509 +33%
Millennium Management
8
Millennium Management
New York
$207K +$234K +158,967 New
IC
9
Ikarian Capital
Texas
$205K
Goldman Sachs
10
Goldman Sachs
New York
$62.3K +$70.5K +47,954 New
HF
11
HRT Financial
New York
$30K +$34.1K +23,162 New
BFM
12
Boothbay Fund Management
New York
$24.5K
Citadel Advisors
13
Citadel Advisors
Florida
$14.5K +$16.4K +11,169 New
BlackRock
14
BlackRock
New York
$7.49K +$2.7K +1,834 +47%
TRCT
15
Tower Research Capital (TRC)
New York
$4.6K +$312 +212 +6%
Bank of America
16
Bank of America
North Carolina
$4.48K +$4.96K +3,372 +4,437%
JP Morgan Chase
17
JP Morgan Chase
New York
$10 -$1 -1 -11%
UBS Group
18
UBS Group
Switzerland
$1 -$35 -24 -96%
Luther King Capital Management (LKCM)
19
Luther King Capital Management (LKCM)
Texas
-$100K -59,662 Closed